ABSTRACT Hyperhomocysteinaemia is considered as an important independent risk factor for atherosclerosis and thrombotic disease. This study determined the distribution of homocysteine (Hcy) levels in healthy Tunisian subjects and evaluated the relationship between Hcy levels and some cardiovascular risk factors. Randomly selected subjects (592 men and 114 women) were recruited from different regions of Tunisia. The overall mean Hcy level was 12.6 (SD 5.4) µmol/L. Hcy levels in subjects with hyperhomocysteinaemia varied according to geographical region. Subjects with hyperhomocysteinaemia had significantly elevated total cholesterol, LDL cholesterol, apolipoprotein A and apolipoprotein B and lower vitamin B 12 levels compared with subjects with normohomocysteinaemia. Hcy levels correlated with total cholesterol (r = 0.09), apolipoprotein A (r = 0.012), and B (r = 0.013) levels and total/HDL cholesterol ratio (r = -0.085). Further epidemiological studies are needed to determine the precise role of Hcy in cardiovascular disease. 
Introduction
Elevated homocysteine (Hcy) concentration has been demonstrated to be a risk factor for cardiovascular disease (CVD) [1, 2] . Evidence now indicates that hyperhomocysteinaemia (Hcy level > 15 µmol/L) is an important independent risk factor for atherosclerosis and thrombotic disease [3] . Although the distribution of plasma concentrations of Hcy has been well reported in some populations in America and Europe, there are no epidemiological studies of Hcy concentrations in healthy subjects from different regions in Tunisia and their impact on CVD risk factors.
In the present study, we aimed to determine the distribution of plasma Hcy levels in healthy Tunisian subjects and to evaluate the relationship between Hcy levels and CVD risk factors.
Methods

Sample
In the present study 706 healthy young adults (592 men and 114 women) were randomly recruited from different regions of Tunisia. Their mean age was 28.0 [standard deviation (SD) 9.1] years old, range 20-71 years. We subdivided subjects into groups according to their geographical origin of residence: north (n = 361), Tunis (the capital) (n = 178), centre (n = 115) and south (n = 52). Exclusion criteria for participants were diabetes mellitus, hypertension, cardiomyopathy, renal failure and current use of vitamins. The study was approved by the local ethics committee and all subjects gave their consent to participate.
Data collection
A questionnaire was completed for each subject about demographic information (age, sex, weight, height, smoking, alcohol consumption). Cigarette smokers were categorized as current smokers (54.2%) or non-smokers (including never smokers and ex-smokers who had quit smoking for at least 6 months before the study). Alcohol consumption was defined as consumers (12.9%) or not of any alcoholic beverages. Body mass index (BMI) was calculated as weight (kg)/height (m 2 ). Blood samples were collected from subjects after 12 hours of fasting. Concentrations of Hcy in plasma were assessed using an automatic analyser (Immulite 2000, Diagnostic Products Corporation) based on a competitive immunoassay and were expressed in µmol/L. Serum vitamin B 12 and folate levels were measured by the autoanalyser based on a competitive immuno assay. Vitamin B 12 and folate levels were expressed in pg/ mL and ng/mL respectively. 
Results
The mean Hcy level of the study group was 19.1 (SD 5.6) µmol/L. There were 541 subjects with normal HCy levels (≤ 15 µmol/L) and 162 with elevated HCy levels (> 15 µmol/L), giving a prevalence of hyperhomocysteinaemia of 22.9%. Table 1 shows the mean Hcy and vitamin levels in healthy people with normal and raised Hcy by sex The mean Hcy concentration was significantly In the normohomocysteinaemia group there were no difference in Hcy levels by region whereas in the hyperhomocysteinaemia group the mean Hcy level was significantly higher in the central region of the country compared with the capital, Tunis city and the southern region (Table 2) .
Vitamin B 12 level was significantly higher in Tunis city than in the central region In the normohomocysteinaemia group but not in the hyperhomocysteinaemia group (Table 2) . Folate levels did not vary by region in either subgroup.
In subjects with hyperhomocysteinaemia the mean Hcy level was significantly lower in those consuming alcohol compared with those not drinking alcohol [18.0 (3.4) µmol/l versus 20.3 (6.8) µmol/L] (P < 0.05) ( Table  3 ). There were no significantly differences by smoking and BMI status.
Subjects with hyperhomocysteinaemia had significantly elevated lipid parameters-total cholesterol, LDL cholesterol, apolipoprotein A and apolipoprotein B-and lower vitamin B 12 levels compared with those with normohomocysteinaemia (Table 4) .
In all studied population, Hcy levels correlated with total cholesterol (r = 0.09, P < 0.05), apolipoprotein A (r = 0.012, P < 0.01) and apolipoprotein B (r = 0.013, P < 0.01).
Discussion
In the present study the prevalence of hyperhomocysteinaemia was 22.9% in this sample of healthy people in Tunisia and the mean value was 12.6 (SD 5.4) µmol/L. The distribution of Hcy in different geographic regions of Tunisia was not homogenous; we found differences in Hcy distribution between residents of the capital city and the centre region of Tunisia but only among those with hyperhomocysteinaemia. Previous studies have reported Hcy concentrations ranging from 6 µmol/L in Japan to 13 µmol/L in South Africa in healthy subjects [4] . In the Iranian population, Hcy concentrations were lower [7. µmol/L] [7] . The similar levels of Hcy in Syria and Morocco compared with our findings may be due to similarities in food intake habits. In the literature, the reasons for variations of plasma Hcy between different countries are not clear. Alfthan et al. argued that intercountry differences in Hcy levels were real and were not due to different sampling or assay procedures [8] . We think that geographical variations in dietary fruit and vegetable intake might explain these intercountry differences between European and Mediterranean countries. In healthy populations, a correct nutritional regimen with sufficient daily intakes of the nutritional determinants of Hcy metabolism is crucial for maintaining Hcy plasma concentrations within the normal range [9] . It has been suggested that a high dietary intake of folate can make a substantial contribution to a reduction in plasma Hcy concentrations in the general population. In fact, each 3 µmol/L decrease in Hcy may be associated with a 16% reduction in the risk of ischaemic heart disease, 25% in the risk of deep vein thrombosis and 24% in the risk of stroke [1] .
Differences in Hcy and folates levels between men and women may be due to differences in lifestyle, such as tobacco use [10] and coffee drinking (which has been demonstrated to diminish vitamin B absorption [11] ). In our study all the tobacco smokers were men, who in Tunisia generally consume coffee while smoking. Syrian smokers had lower folates levels compared with ex-smokers and never smokers, a fact which may have explained the higher Hcy levels found in men than women [6] . In the literature, differences in Hcy concentrations between men and women have been explained by the effect of oestrogen on Hcy metabolism [12] , with remethylation being more effective in premenopausal women than in men. This hypothesis is supported by the decreased levels of Hcy after hormone treatment in menopausal women [13] .
Tobacco smoking is considered to be a CVD risk factor. Jendricko T et al. found that war veterans who were nonsmokers had higher Hcy levels than did smokers [14] . Other studies found a positive correlation between Hcy levels and tobacco use [15] and significantly lower plasma concentrations of pyridoxal phosphate in smokers compared with non-smokers [16] . Smokers with high plasma Hcy are at greatly increased risk of CVD. These subjects had reduced levels of B vitamins that modulate Hcy metabolism [10] . In our results, low Hcy concentrations in men may have been due, in part, to the effect of alcohol consumption, as alcohol drinkers had significantly lower Hcy levels. In fact studies have reported the favourable action of alcohol on lowering Hcy, and that this depends on the type of alcoholic beverage [17, 18] .
Boushey et al. estimated that an elevation of 5 µmol/L in Hcy levels is equivalent to an increase of 20 mg/ dL in cholesterol [19] . Hcy has been demonstrated to induce both atherogenic and thrombogenic mediators in cultured vascular cells [20] and cause endothelial dysfunction in humans [21, 22] . In fact, increasing synthesis of Hcy may have an effect on the progression of atherogenesis [23, 24] . Yadav et al., however, did not find a significant correlation between plasma Hcy and total cholesterol, HDL cholesterol or triglycerides [25] . Holven et al. suggested that hyperhomocysteinaemic individuals have dysfunctional HDL particles with attenuated antiatherogenic activity and that this may represent a novel explanation for the increased risk of cardiovascular events in these individuals [26] . In a recent study, Zinellu et al. demonstrated that intracellular reactive oxygen species production induced by Hcy-S-LDL might be responsible for the observed human [28, 29] . In the Atherosclerosis Risk in Communities study, apolipoprotein A was found to be strongly predictive when considered alone, but did not contribute to the risk prediction when considered with LDL cholesterol, HDL cholesterol and TG [30] . A prospective study from the United Kingdom in men followed up for 6 years, showed that apolipoprotein B was a better predictor of risk than total cholesterol or LDL cholesterol and that the ratio of apolipoprotein B/A was associated with the strongest effect on risk [31] . In a recent research, Ravnskov et al. demonstrated that homocysteine thiolactone reacted with the free amino groups of apolipoprotein-B to form homocysteinylated LDL lipoprotein and caused obstruction of the circulation in the vasa vasorum [32] .
Conclusion
The elevation of Hcy levels is considered as a risk factor for CVD. In this study of healthy young adults, hyperhomocysteinaemia was associated with significantly elevated total cholesterol, LDL cholesterol, apolipoprotein A and apolipoprotein B and lower vitamin B 12 levels compared with subjects with normohomocysteinaemia. Further epidemiological studies are needed to determine the precise role of Hcy.
